CAS 79350-37-1 Pharmaceutical Cefixime Powder Raw Material Cefixime

• Customization: Available
• CAS No.: 79350-37-1
• Formula: C16h15n5o7s2
• Model NO.: QS-cefixime
• EINECS: 616-684-4
• Packaging Material: Metal
• Storage Method: Normal
• Shelf Life: >12 Months
• Nutrient Composition: Cefixime
• Resource: Cefixime
• The content of active substances: >99%
• Certification: GMP, Hse, ISO 9001, USP, Bp
• Product Name: Cefixime
• Name: Cefixime Powder
• Appearance: White Powder
• Color: White
• Grade: Pharmaceutical Grade
• Assay: 99%
• Test Method: HPLC
• Mf: C16h15n5o7s2
• Density: 1.85 g/cm3
• Melting Point: 218-225°c
• Boiling Point: 200°c
• MW: 507.5g/Mol
• Application: Pharmaceutical
• Refractive Index: 1.811
• Transport Package: Negotiable
• Specification: Negotiable
• Trademark: QS-cefixime
• Origin: Shaanxi Xi′an
• Production Capacity: 2000kg/Month

Product Description

CAS 79350-37-1 Pharmaceutical cefixime Powder  Raw Material cefixime

Product Description

Product Details

Product Name	cefixime
CAS NO	79350-37-1
Molecular Formula	C16H15N5O7S2
Molecular Weight	507.5g/mol
Appearance	White Powder

Cefixime is an organic compound with the chemical formula C16H15N5O7S2. It is a third-generation cephalosporin antibiotic used orally and is suitable for treating respiratory, urinary, and biliary tract infections caused by sensitive bacteria. Cefoxime is highly stable against β - lactases produced by gram-negative bacteria, and has a stronger antibacterial effect against gram-negative bacteria than first and second generation cephalosporins. Its antibacterial effect against gram-positive cocci is not as good as first and second generation cephalosporins. The cephalosporin drugs approved by the State Food and Drug Administration include various dosage forms such as tablets, capsules, dispersible tablets, dry suspensions, and granules, all of which are prescription drugs.

Application&Function

1. Respiratory system infections, such as bronchitis, pneumonia, etc;
2. Urinary system infections, such as pyelonephritis, cystitis, urethritis, etc;
3. Biliary tract infections, such as cholecystitis and cholangitis;
4. Other conditions such as otitis media, sinusitis, scarlet fever, etc.
 

Specification